NIBSC18/144 WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis 18/144
产品详情如下，更多产品详情，请咨询客服，供实验室使用！
| Product description | WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis |
| Product number | 18/144 NIBSC18/144 |
| Category | Biotherapeutics Gene Therapy |
| Keywords | Lentiviral vector, integration site analysis, gene therapy, genomic DNA |
| Type of standard | International Standard |
| Customer notes | freeze-dried human genomic DNAs carrying various LV integration sites intended purpose: primary standards for calibration of secondary standards (commercial/regional/inhouse), assays. Shipped at ambient temperature. Available internationally. |
| Instructions for Use | 18-144.pdf Instructions for Use |
| Minimum quantity | 1 |
部分相关产品如下，更多相关产品的详细信息，请咨询客服，供实验室使用！
Related Products
101047 Inactivated (Acetic Acid + Heat)SARS-CoV-2 Omicron (BA.1 sublineage) 灭活（乙酸+热）严重急性呼吸系统综合征冠状病毒2型奥密克戎（BA.1亚系）
100987 Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 灭活的严重急性呼吸系统综合征冠状病毒2型（BetaCoV/澳大利亚/VIC01/2020 100988 Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 灭活的严重急性呼吸系统综合征冠状病毒2型的核酸提取物（BetaCoV/澳大利亚/VIC01/2020